Valuation: Sartorius Stedim Biotech SA

Market Cap 17.54B 20.24B 16.44B 14.99B 28.21B 1,932B 28.67B 194B 75.59B 967B 75.98B 74.34B 3,225B P/E 2026 *
46.2x
P/E 2027 * 35.8x
Enterprise Value 19.55B 22.56B 18.33B 16.71B 31.45B 2,153B 31.95B 216B 84.25B 1,078B 84.69B 82.85B 3,595B EV / Sales 2026 *
6.25x
EV / Sales 2027 * 5.57x
Free-Float
28.47%
Yield 2026 *
0.47%
Yield 2027 * 0.57%
Manager TitleAgeSince
Chief Executive Officer 51 2023-03-27
Chief Tech/Sci/R&D Officer 61 2011-09-07
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 2015-04-06
Director/Board Member 69 2015-04-06
Director/Board Member 69 2017-09-13
Change 5-day change 1-year change 3-year change Capi.($)
-0.35%+2.45%-14.52%+4.25% 192B
-0.14%+5.47%-2.46%+8.97% 116B
-0.12%-3.70%+7.54%+66.80% 59.95B
+2.11%+2.55%+34.34%+62.10% 54.64B
-0.75%+3.21%-6.74%-35.34% 50B
-0.35%+9.02%+13.19%-21.81% 34.26B
+0.59%+3.20% - - 31.15B
-1.35%-0.24%+41.24%-13.03% 24.79B
+0.85%+14.53%-3.89%+20.23% 24.07B
Average +0.06%+4.23%+8.59%+11.52% 65.22B
Weighted average by Cap. -0.03%+4.27%+0.54%+12.42%

Financials

2026 *2027 *
Net sales 3.13B 3.61B 2.93B 2.67B 5.03B 344B 5.11B 34.51B 13.47B 172B 13.54B 13.25B 575B 3.47B 4B 3.25B 2.96B 5.57B 382B 5.66B 38.26B 14.94B 191B 15.01B 14.69B 637B
Net income 379M 437M 355M 324M 610M 41.74B 619M 4.18B 1.63B 20.89B 1.64B 1.61B 69.69B 481M 555M 451M 411M 774M 52.96B 786M 5.31B 2.07B 26.51B 2.08B 2.04B 88.43B
Net Debt 2.01B 2.32B 1.88B 1.72B 3.23B 221B 3.28B 22.18B 8.66B 111B 8.7B 8.52B 370B 1.76B 2.03B 1.65B 1.51B 2.84B 194B 2.88B 19.46B 7.6B 97.18B 7.64B 7.47B 324B
Logo Sartorius Stedim Biotech SA
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-